Improving cancer treatment for people living with HIV
(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV
This study is looking at how people with HIV experience cancer treatment, especially for cancers that aren't related to AIDS, to find out what challenges they face and how well treatments like chemotherapy and radiation work for them, so we can improve care and support for these patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11086674 on NIH RePORTER |
What this research studies
This research investigates the disparities in cancer treatment and outcomes for individuals living with HIV, particularly focusing on non-AIDS-defining cancers. It aims to understand the barriers to initiating and completing cancer therapy, as well as the safety and efficacy of treatments like chemotherapy and radiation therapy in this population. By evaluating the entire cancer care delivery process, the study seeks to identify critical areas for improvement to enhance patient outcomes. The research will also assess the long-term health needs of cancer survivors with HIV, addressing potential chronic health conditions that may arise after treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are diagnosed with non-AIDS-defining cancers.
Not a fit: Patients who do not have HIV or those without a cancer diagnosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment protocols and better health outcomes for patients living with HIV.
How similar studies have performed: While there have been studies on cancer treatment initiation rates for certain cancers in this population, this research aims to comprehensively evaluate the entire cancer care delivery process, making it a novel approach.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Silverberg, Michael J — Kaiser Foundation Research Institute
- Study coordinator: Silverberg, Michael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.